DE602006004610D1 - Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung - Google Patents

Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung

Info

Publication number
DE602006004610D1
DE602006004610D1 DE602006004610T DE602006004610T DE602006004610D1 DE 602006004610 D1 DE602006004610 D1 DE 602006004610D1 DE 602006004610 T DE602006004610 T DE 602006004610T DE 602006004610 T DE602006004610 T DE 602006004610T DE 602006004610 D1 DE602006004610 D1 DE 602006004610D1
Authority
DE
Germany
Prior art keywords
carvedilol
pharmaceutical composition
controlled release
containing pharmaceutical
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602006004610T
Other languages
English (en)
Inventor
Pal Fekete
Zoltan Budavari
Zsolt Zsigmond
Agnes Bozso
Huszar Magdolna Leventiszne
Zoltanne Palfi
Palne Szentgroti
Karacs Erika Davidne
Kuncze Aniko Turoczine
Krisztina Abraham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Publication of DE602006004610D1 publication Critical patent/DE602006004610D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006004610T 2005-08-26 2006-08-23 Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung Expired - Fee Related DE602006004610D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500803A HU227490B1 (en) 2005-08-26 2005-08-26 Sustained release pharmaceutical preparation containing carvedilol
PCT/HU2006/000068 WO2007023325A2 (en) 2005-08-26 2006-08-23 Controlled release pharmaceutical composition containing carvedilol

Publications (1)

Publication Number Publication Date
DE602006004610D1 true DE602006004610D1 (de) 2009-02-12

Family

ID=89986232

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006004610T Expired - Fee Related DE602006004610D1 (de) 2005-08-26 2006-08-23 Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung

Country Status (11)

Country Link
EP (1) EP1928431B8 (de)
AT (1) ATE418969T1 (de)
DE (1) DE602006004610D1 (de)
DK (1) DK1928431T3 (de)
EA (1) EA013058B1 (de)
ES (1) ES2321980T3 (de)
HU (1) HU227490B1 (de)
NO (1) NO20081481L (de)
PL (1) PL1928431T3 (de)
PT (1) PT1928431E (de)
WO (1) WO2007023325A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
AR062321A1 (es) * 2006-08-25 2008-10-29 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo
HU227881B1 (en) * 2007-02-23 2012-05-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Sustained release pharmaceutical preparation containing carvedilol
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
US9700520B2 (en) 2007-09-21 2017-07-11 Evonik Roehm Gmbh PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
WO2009047800A2 (en) * 2007-10-09 2009-04-16 Lupin Limited Oral controlled release composition of carvedilol
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN103099793B (zh) * 2013-02-06 2015-07-15 中国人民解放军第二军医大学 片剂及其制备方法
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1335707A4 (de) * 2000-10-24 2005-07-06 Smithkline Beecham Corp Neue carvedilol-formulierungen
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
AU2003288608A1 (en) * 2002-12-20 2004-07-14 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems

Also Published As

Publication number Publication date
EA200800666A1 (ru) 2008-06-30
WO2007023325A2 (en) 2007-03-01
WO2007023325A3 (en) 2007-06-28
PT1928431E (pt) 2009-03-25
EP1928431A2 (de) 2008-06-11
HUP0500803A3 (en) 2008-03-28
HU227490B1 (en) 2011-07-28
ES2321980T3 (es) 2009-06-15
HU0500803D0 (en) 2005-11-28
EA013058B1 (ru) 2010-02-26
PL1928431T3 (pl) 2009-07-31
EP1928431B8 (de) 2009-04-08
NO20081481L (no) 2008-05-19
HUP0500803A2 (en) 2007-05-29
ATE418969T1 (de) 2009-01-15
EP1928431B1 (de) 2008-12-31
DK1928431T3 (da) 2009-04-20

Similar Documents

Publication Publication Date Title
DE602006004610D1 (de) Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung
WO2009113703A3 (en) Orally-disintegrating solid preparation
IL181117A (en) Sustained drug release composition demonstrating an ascending zero order release pattern and methods of manufacturing such a composition
TR201902233T4 (tr) Hızlı çözünen katı dozaj formu.
WO2009036253A3 (en) Medical devices having bioerodable layers for the release of therapeutic agents
WO2007041367A3 (en) Oral composition containing a salivation inducing agent
DE502007002695D1 (de) Retardtabletten mit Hydromorphon
RS54929B1 (sr) Formulacija i metod obložene tablete
DE502005009109D1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
JP2011509921A5 (de)
CL2009000550A1 (es) Metodo para mantener el estado de latencia de una semilla y evitar la germinacion de la misma que comprende revestir dicha semilla con una composicion que comprende particulas que contienen un material de nucleo, el cual comprende un material de cambio de fase.
WO2011063089A3 (en) Surface-modified adhesives
MX339587B (es) Pelicula que se puede rotular con laser resistente al calor.
EP1988138A4 (de) Beschichtungszusammensetzung, gehärteter film und harzlaminat
MX280211B (es) Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo.
TWI370160B (en) Conductive polymer coating composition, method of preparing coating film using the conductive polymer coating composition, and coating film prepared using the method
CL2012002909A1 (es) Procedimiento de preparación de una composición farmacéutica que comprenden a) un centro granulado constituido por granos de principio activo aglomerados en presencia de aglomerante y b) una capa de recubrimiento de dicho centro granulado constituido por matriz grasa; composición farmacéutica; y su uso para administración oral
WO2008139136A3 (en) Sensor coating
MX2010007577A (es) Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon.
EP2368546A4 (de) Pharmazeutische zusammensetzung für die gesteuerte freisetzung von methylphenidat
BRPI0922341A2 (pt) composição farmacêutica revestida em fusão com liberação rápida.
WO2007080509A3 (en) Sustained release compositions of alfuzosin
TR201819108T4 (tr) Kontrollü salımlı matrisli farmasötik dozaj formülasyonu.
DK2083638T3 (da) Smagsfrigivende kerner og deres anvendelse i tyggegummi
WO2009023761A3 (en) Pharmaceutical compositions comprising ropinirole

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee